JPMorgan Chase & Co’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $895 | Sell |
710
-803,844
| -100% | -$1.01M | ﹤0.01% | 5748 |
|
|
2025
Q1 | $735K | Sell |
804,554
-1,691,368
| -68% | -$1.54M | ﹤0.01% | 3822 |
|
|
2024
Q4 | $3.97M | Buy |
2,495,922
+2,062,563
| +476% | +$3.28M | ﹤0.01% | 2927 |
|
|
2024
Q3 | $849K | Sell |
433,359
-30,668
| -7% | -$60.1K | ﹤0.01% | 3737 |
|
|
2024
Q2 | $761K | Sell |
464,027
-85,026
| -15% | -$139K | ﹤0.01% | 3648 |
|
|
2024
Q1 | $2.82M | Sell |
549,053
-27,931
| -5% | -$144K | ﹤0.01% | 2928 |
|
|
2023
Q4 | $3.31M | Buy |
576,984
+4,606
| +0.8% | +$26.4K | ﹤0.01% | 2823 |
|
|
2023
Q3 | $2.74M | Sell |
572,378
-19,804
| -3% | -$94.7K | ﹤0.01% | 2811 |
|
|
2023
Q2 | $2.52M | Sell |
592,182
-10,796
| -2% | -$45.9K | ﹤0.01% | 2902 |
|
|
2023
Q1 | $3.2M | Buy |
602,978
+2,881
| +0.5% | +$15.3K | ﹤0.01% | 2732 |
|
|
2022
Q4 | $3.77M | Sell |
600,097
-1,253
| -0.2% | -$7.87K | ﹤0.01% | 2567 |
|
|
2022
Q3 | $6.34M | Buy |
601,350
+91,782
| +18% | +$968K | ﹤0.01% | 2158 |
|
|
2022
Q2 | $2.77M | Sell |
509,568
-6,190
| -1% | -$33.6K | ﹤0.01% | 2804 |
|
|
2022
Q1 | $4.74M | Buy |
515,758
+497,692
| +2,755% | +$4.57M | ﹤0.01% | 2604 |
|
|
2021
Q4 | $273K | Buy |
18,066
+11,002
| +156% | +$166K | ﹤0.01% | 4373 |
|
|
2021
Q3 | $169K | Buy |
+7,064
| New | +$169K | ﹤0.01% | 4490 |
|